World Orphan Drug Congress
The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.
12 events found.
BIO Europe 2023
This panel will discuss what the legislation brings, its potential impact on businesses and what needs to be done to change the legislation in its journey to a final version, that it works for both, the biotech ecosystem, maintaining innovation pipelines, and patients.
Featured
EuropaBio Patient BioForum 2023 Roundtable on Advancing Solutions for Unmet Medical Needs
Hybrid Event | Invitation Only EuropaBio’s Patient BioForum meets annually to facilitate the exchange of views and expertise on scientific, regulatory, and policy issues between patient […]
Featured
EFIB 2023 Rotterdam Statement wider launch
Industrial biotechnology for a sustainable and resilient global Europe As the EU looks ahead to the European elections in 2024, with a new EU Commission mandate […]
IHI Call Days – Calls 6 & 7
The IHI Call Days are your one-stop-shop to get detailed information on our calls for proposals and network with potential partners for your consortium.
EU pharmaceutical legislation – Europe’s biotech innovation in the balance?
Event agenda 12:00: Registration opens 12:30: Panel starts 13:45: Panel close and networking lunch 15:00: Close Confirmed Speakers Tomislav Sokol MEPMember SANT Committee, European Parliament Hilde […]
Europe Rare Disease Summit 2024
Join our very own Healthcare Policy Senior Manager, Adrien Samson in Madrid where he will be speaking in the panel "Innovation, Funding and Access to Orphan Drugs: Challenges and Opportunities" between 12:15 and 13:00.
Made in Belgium for Europe, National Associations’ Council Presidency Summit
Whether it’s microorganisms revolutionising manufacturing or advanced therapies for rare disease patients, biotechnology is leading the way, and Belgium is on it. If you are a […]
International Congress on Rare Diseases and Orphan Drugs 2024
Join us on 7 March to discuss the impact of revision of the EU’s General Pharmaceutical Legislation (GPL) on Europe’s innovation ecosystem and biotechnology companies.
EuropaBio Webinar – How will the revision EU General Pharmaceutical Legislation impact Europe’s innovation ecosystem and biotechnology companies?
Join us on 7 March to discuss the impact of revision of the EU’s General Pharmaceutical Legislation (GPL) on Europe’s innovation ecosystem and biotechnology companies.
Featured
Biomanufacturing Policy Summit 2024 – Policy pathways for biomanufacturing in Europe
The Biomanufacturing Policy Summit will host its 2nd edition in March 2024. The invite-only half-day summit hosted by EuropaBio brings together stakeholders including industry representatives and […]
Industrial biotech: Is Europe ready to harness its potential?
A Science | Business closed-door roundtable, organised in partnership with EuropaBio – followed by networking reception Only By Invitation For more information, please contact: denitsa.nikolova@sciencebusiness.ne